Biological Psychiatry
Volume 67, Issue 3 , Pages 270-274 , 1 February 2010

Retinal Response to Light in Young Nonaffected Offspring at High Genetic Risk of Neuropsychiatric Brain Disorders

Received 21 May 2009 ,Revised 2 August 2009 ,Accepted 3 August 2009.

References 

  1. Lavoie MP, Lam RW, Bouchard G, Sasseville A, Charron MC, Gagné AM, et al. Evidence of a biological effect of light therapy on the retina of patients with seasonal affective disorder. Biol Psychiatry. 2009;66:253–258
  2. Hébert M, Dumont M, Lachapelle P. Electrophysiological evidence suggesting a seasonal modulation of retinal sensitivity in subsyndromal winter depression. J Affect Disord. 2002;68:191–202
  3. Hébert M, Beattie C, Tam E, Yatham L, Lam R. Electroretinography in patients with winter seasonal affective disorder. Psychiatry Res. 2004;127:27–34
  4. Balogh Z, Benedek G, Keri S. Retinal dysfunctions in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:297–300
  5. Warner R, Laugharne J, Peet M, Brown L, Rogers N. Retinal function as a marker for cell membrane omega-3 fatty acid depletion in schizophrenia: A pilot study. Biol Psychiatry. 1999;45:1138–1142
  6. Ritvo ER, Creel D, Realmuto G, Crandall AS, Freeman BJ, Bateman JB, et al. Electroretinograms in autism: A pilot study of b-wave amplitudes. Am J Psychiatry. 1988;145:229–232
  7. Jaffe MJ, Bruno G, Campbell G, Lavine RA, Karson CN, Weinberger DR. Ganzfeld electroretinographic findings in Parkinsonism: Untreated patients and the effect of levodopa intravenous infusion. J Neurol Neurosurg Psychiatry. 1987;50:847–852
  8. Filip V, Balik J. Possible indication of dopaminergic blockade in man by electroretinography. Int Pharmacopsychiatry. 1978;13:151–156
  9. Fornaro P, Dell'Osso L, Perossini M, Placidi GF, Castrogiovanni P. Effects of nomifensine on dopaminergic transmission in healthy volunteers evaluated by means of the electroretinographic technique. Acta Neurol (Napoli). 1984;6:5–10
  10. Holopigian K, Clewner L, Seiple W, Kupersmith MJ. The effects of dopamine blockade on the human flash electroretinogram. Doc Ophthalmol. 1994;86:1–10
  11. Castrogiovanni P, Di Muro A, Maremmani I, Perossini M, Marazziti D. Interaction between the serotonin and dopamine systems in humans: Preliminary findings. Brain Res. 1989;504:129–131
  12. Porciatti V, Bagnoli P, Alesci R, Fontanesi G. Pharmacological dissociation of the b-wave and pattern electroretinogram. Doc Ophthalmol. 1987;65:377–383
  13. Maziade M, Roy M-A, Chagnon Y, Cliche D, Fournier J, Montgrain N, et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: A dense genome scan in Eastern Quebec families. Mol Psychiatry. 2005;10:486–499
  14. Maziade M, Chagnon YC, Roy MA, Bureau A, Fournier A, Mérette C. Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: The relevance for redefining phenotype. Eur J Hum Genet. 2009;17:1034–1042
  15. Mérette C, Roy MA, Bureau A, Fournier A, Emond C, Cliche D, et al. Replication of linkage with bipolar disorder on chromosome 16p in the Eastern Quebec population. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:737–744
  16. Braff DL, Freedman R, Schork NJ, Gottesman I. Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull. 2007;33:21–32
  17. Maziade M, Rouleau N, Gingras N, Boutin P, Paradis M-E, Jomphe V, et al. Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in Eastern Quebec multigenerational families. Schizophr Bull. 2009;35:919–930
  18. Szatmari P, Maziade M, Zwaigenbaum LZ, Mérette C, Roy MA, Joober R, et al. Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet. 2007;144:581–588
  19. Maziade M, Palmour R, Phaneuf D, Mérette C, Roy M-A. Schizophrenia and bipolar disorder: Linkage on chromosomes 5 and 11. In:  Cooper DN editors. Nature Encyclopedia of the Human Genome. Vol 1:London: Macmillan Publishers Ltd, Nature Publishing Group; 2003;p. 178–181
  20. Murray RM, O'Callaghan E, Castle DJ, Lewis SW. A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull. 1992;18:319–331
  21. Maziade M, Gingras N, Rouleau N, Poulin S, Jomphe V, Paradis ME, et al. Clinical diagnoses in offspring from Eastern Québec multigenerational families densely affected by schizophrenia or bipolar disorder. Acta Psychiatr Scand. 2008;117:118–126
  22. Hébert M, Lachapelle P, Dumont M. Reproducibility of electroretinograms recorded with DTL electrodes. Doc Ophthalmol. 1995;91:333–342
  23. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980–988
  24. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID) I: History, rationale and description. Arch Gen Psychiatry. 1992;49:624–629
  25. Hans SL, Auerbach JG, Styr B, Marcus J. Offspring of parents with schizophrenia: Mental disorders during childhood and adolescence. Schizophr Bull. 2004;30:303–315
  26. Roy M-A, Lanctôt G, Mérette C, Cliche D, Fournier J-P, Boutin P, et al. Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure. Am J Psychiatry. 1997;154:1726–1733
  27. Goldstein H. Multilevel models. In:  Armitage P,  Colton T editor. Encyclopedia of Biostatistics. Vol 4:Chichester, United Kingdom: John Wiley and Sons Ltd; 1998;p. 2725–2731
  28. Kelley K. Confidence intervals for standardized effect sizes: Theory, application, and implementation. J Stat Softw. 2007;20:1–24
  29. Westrin A, Lam RW. Seasonal affective disorder: A clinical update. Ann Clin Psychiatry. 2007;19:239–246
  30. Schretlen DJ, Cascella NG, Meyer SM, Kingery LR, Testa SM, Munro CA, et al. Neuropsychological functioning in bipolar disorder and schizophrenia. Biol Psychiatry. 2007;62:179–186
  31. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet C Semin Med Genet. 2003;123C:59–64

PII: S0006-3223(09)01015-4

doi: 10.1016/j.biopsych.2009.08.016

Biological Psychiatry
Volume 67, Issue 3 , Pages 270-274 , 1 February 2010

Article Tools

* Image Usage & Resolution